Sai Life Sciences Limited
Sai Life Sciences Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: SAILIFE and BSE: 544306 (ISIN INE570L01029).
It has a market capitalisation of ₹29,562 crore, a last close of ₹1,396 on 2026-10-19, a one-year return of 60.1%.
Valuation: a price-to-earnings ratio of 81.72x, a price-to-book ratio of 11.90x, a dividend yield of 0.0%.
Profitability: return on equity of 15.1%, return on capital employed of 19.4%, an operating margin of 29.3%.
Balance sheet and ownership: debt-to-equity of 0.04x, promoter holding of 34.5%.
| Metric | Value |
|---|---|
| Market capitalisation | 29,562 |
| Last close | ₹1,396 |
| P/E (TTM) | 81.72x |
| P/B | 11.90x |
| Dividend yield | 0.0% |
| ROE (FY) | 15.1% |
| ROCE (FY) | 19.4% |
| Operating margin (TTM) | 29.3% |
| Debt / equity | 0.04x |
| Promoter holding | 34.5% |
| 1-year return | 60.1% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means